The Healthcare CEO’s Guide to Negotiating Rollover Equity Like a Pro
The Healthcare CEO’s Guide to Negotiating Rollover Equity Like a Pro Key Takeaways Rollover Equity 101: The Real Trade Rollover equity means reinvesting part of your sale proceeds into the new platform so your interests align with the buyer’s growth plan. In healthcare, this shows up often in PE, MSO, and DSO-style deals. The practical […]
Read More
How Healthcare Business Brokers Package Small Group Practices for Premium Outcomes
How Healthcare Business Brokers Package Small Group Practices for Premium Outcomes Key Takeaways Why Packaging Beats “Selling Harder” Packaging is the buyer-confidence product: clean financials, clean story, clean risk profile. In selective deal environments, prepared assets get more attention and tighter terms.MedBridge’s pre-sale framework, Maximize Practice Sale Value, is built around reducing surprises before buyers […]
Read More
What Healthcare CEOs Should Ask About a Healthcare Advisor’s Buyer Relationships (And Proof)
What Healthcare CEOs Should Ask About a Healthcare Advisor’s Buyer Relationships (And Proof) Key Takeaways Why Buyer Relationships Determine Valuation, Speed, and Deal Certainty In healthcare M&A, outcomes are rarely accidental. Valuation strength, timeline efficiency, and closing certainty are directly influenced by the depth of an advisor’s buyer relationships. According to Bain & Company’s Global […]
Read More
The Healthcare “Advisor Scorecard” CEOs Can Use to Compare Firms (Beyond Fees)
The Healthcare “Advisor Scorecard” CEOs Can Use to Compare Firms (Beyond Fees) Key Takeaways Why Choosing the Right Healthcare M&A Advisor Matters More Than Fees When CEOs of medical or dental practices begin exploring a sale or partnership, one of the first questions they ask is, “How much will the advisor cost?” While fees are […]
Read More
What a Healthcare CEO Should Demand From an M&A Advisor in 2026
What a Healthcare CEO Should Demand From an M&A Advisor in 2026 Key Takeaways Introduction The healthcare mergers and acquisitions landscape is evolving faster than ever. Rising interest rates, increasing regulatory pressure, private equity expansion, and digital transformation are all reshaping how deals are structured. For healthcare CEOs, this means that selling, merging, or partnering […]
Read More
Preparing for Multiple Exit Scenarios at the Same Time
Preparing for Multiple Exit Scenarios at the Same Time Key Takeaways Why Exit Planning Looks Different in Today’s Healthcare Market Healthcare business owners are operating in one of the most complex exit environments in recent memory. Consolidation continues, private equity remains active but selective, DSOs and MSOs are evolving their acquisition models, and regulatory pressure […]
Read More